PAS
EDIT icon

Point72 Asia (Singapore)’s Editas Medicine EDIT Stock Holding History

Point72 Asia (Singapore)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-36,343
Closed -$46.2K – 961
2024
Q4 		$46.2K Sell
36,343
-57,446
-61% -$146K 0.01% 519
2024
Q3 		$320K Buy
+93,789
New +$408K 0.06% 260
2024
Q1 		– Sell
-3,657
Closed -$37K – 1111
2023
Q4 		$37K Buy
+3,657
New +$32.1K 0.01% 358

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Point72 Asia (Singapore)'s EDIT Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 36,343 shares — an estimated $46.2K sold.

Point72 Asia (Singapore) first reported a position in EDIT in Q4 2023 and held it in 3 quarters. The position peaked at $320K in Q3 2024. 194 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 36,343 Editas Medicine shares in Q1 2025, an estimated $46.2K.
  • Point72 Asia (Singapore) first reported a position in Editas Medicine in Q4 2023 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Editas Medicine position peaked at $320K in Q3 2024.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.